Abstract:Xinjing Gao, 1– 4 Wenjiao Wang 1– 4 1 Department of Critical Care Medicine, The Third Central Hospital of Tianjin, Tianjin, People's Republic of China; 2 Nankai University Affiliated Third Central Hospital, Nankai University, Tianjin, People's Republic of China; 3 Tianjin Key Laboratory of Extracorporeal Life Support for Critical Diseases, The Third Central Hospital of Tianjin, Tianjin, People's Republic of China; 4 Artificial Cell Engineering Technology Research Center, The Third Central Hospital of Tianjin, Tianjin, People's Republic of China Correspondence: Wenjiao Wang, Tel +86-22-84112109, Fax +86-22-84112095, Email Purpose: Infections induced by multidrug-resistant (MDR) pathogens are one of the most common and serious complications in extracorporeal membrane oxygenation (ECMO) patients. However, there is currently little research about "ECMO and MDR bacteria". The purpose of our study was to clarify the epidemiological characteristics of MDR bacteria and provide references for empiric antibiotic treatments according to the drug susceptibility tests for ECMO patients. Patients and Methods: There were 104 patients admitted to our department and receiving ECMO treatments between January 2014 and December 2022. Altogether, 61 veno-arterial ECMO (VA-ECMO) and 29 veno-venous ECMO (VV-ECMO) patients enrolled. The data on other intensive care unit (ICU) patients in our department in the same period are summarized. Results: A total of 82 MDR bacteria were detected from ECMO patients, and most of these were MDR Gram-negative bacteria (MDR-GNB). There were also 5559 MDR-GNB collected from other patients in our department in the same period. We found that the distribution of MDR-GNB in ECMO patients was different from other critical patients. The proportion of Klebsiella pneumoniae (MDR-KP) in VV-ECMO patients was higher than other critical patients (35.1% and 21.3%, respectively). Moreover, the proportions of MDR Acinetobacter baumannii (MDR-AB) of VA-ECMO and VV-ECMO were higher than other critical patients (54.6%, 43.2% and 30.5%, respectively). In addition, MDR-AB and MDR-KP in ECMO patients exhibited higher percentages of drug resistance to possibly appropriate antibiotics for other critical patients, but showed better sensitivity to colistin. Conclusion: Infections induced by MDR-GNB in ECMO patients were serious and exhibited higher degrees of drug resistance compared with other ICU patients. Colistin might be an option to consider if there is no medical contraindication. However, widespread use of broad spectrum antibiotics is something that should be discouraged, and alternative options are being explored. Keywords: multidrug-resistant Gram-negative bacteria, MDR-GNB, multidrug-resistant Klebsiella pneumoniae , MDR-KP, multidrug-resistant Acinetobacter baumannii , MDR-AB, colistin Infections caused by multidrug-resistant (MDR) pathogens are a serious problem worldwide, and lead to worsening conditions, prolonged hospital stay and increased costs. 1,2 The overuse/misuse of antibiotics against pathogens has allowed the emergence of MDR bacteria due to relevant resistant genes. 3 Patients receiving extracorporeal membrane oxygenation (ECMO) treatment, which helps patients with lungs or heart not working normally and uses an artificial lung to oxygenate blood outside the body, are at high risk for MDR infections due to the immunodeficiency caused by severe illness and the applications of invasive life support measures. 4 Although clinicians have accumulated rich experience in the application of ECMO, infections induced by MDR bacteria are still one of the most common and serious complications. 5 Timely and targeted empirical antibiotic therapies against MDR pathogens are effective measures to improve the situation. Next-generation sequencing (NGS) allows faster acquisition of metagenomic data, but is expensive and not widely available. Bacterial culture as the "gold standard" for diagnosis take too long and therefore miss the best time for anti-infection therapies for ECMO patients. Thus, valid clinical data about etiological characteristics of MDR pathogens and anti-infection experiences against them are important references for early and effective treatments for ECMO patients. A study recently observed that infections induced by Gram-negative bacteria were the majority in trauma patients requiring ECMO support, and advocated that empiric antibiotics should have broad spectrum coverage of Gram-negative organisms in this population. 6 The incidence of MDR and extended-spectrum β-lactamase Gram-negative (ESBL GN) bacteria in adult patients undergoing lung transplantation (LT) was -Abstract Truncated-

Infection Factors for Patients Treated with Extracorporeal Membrane Oxygenation

Nosocomial Infections in Nonsurgical Patients Undergoing Extracorporeal Membrane Oxygenation: A Retrospective Analysis in a Chinese Hospital

[A Case-Control Study on Risk Factors for Nosocomial Infection by Extended-Spectrum Beta-Lactamases-producing Bacteria].

Critically Ill Patients with COVID-19 with ECMO and Artificial Liver Plasma Exchange

Nosocomial Infection in Paediatric Patients Undergoing Extracorporeal Membrane Oxygenation: A Systematic Review and Meta-analysis

Frequency, characteristics, and outcome of adult patients with multiple consecutive health care-associated infections undergoing extracorporeal membrane oxygenation: A retrospective analysis

[Research progress on the extracorporeal membrane oxygenation intubation-related infection]

The Etiological and Drug Resistance Characteristics of Multidrug-Resistant Pathogens in Patients Requiring Extracorporeal Membrane Oxygenation: A Retrospective Cohort Study

[Risk factors associated with in-hospital mortality in patients requiring extracorporeal membrane oxygenation in the perioperative period of heart transplantation]

Risk factors for mortality in patients receiving extracorporeal membrane oxygenation

Extracorporeal membrane oxygenation in immunocompromised patients with acute respiratory failure: A retrospective cohort study

Comparison of mNGS and conventional culture in non-organ transplant critically ill patients supported by ECMO: a single-center study

[Patients of Escherichia Coli Bloodstream Infection: Analysis of Antibiotic Resistance and Predictors of Mortality].

Mechanical Ventilation during Extracorporeal Membrane Oxygenation in Patients with Acute Severe Respiratory Failure

Cross-sectional study for the clinical application of extracorporeal membrane oxygenation in Mainland China, 2018

Healthcare-associated infections in patients with severe COVID-19 supported with extracorporeal membrane oxygenation: a nationwide cohort study

The application of extracorporeal membrane oxygenation in critically ill patient

Nosocomial Infections in Adults Receiving Extracorporeal Membrane Oxygenation: A Review for Infectious Diseases Clinicians

Prolonged Length of Stay in the Emergency Department and Increased Risk of Hospital Mortality in Patients with Sepsis Requiring ICU Admission

Bloodstream infections in COVID-19 patients undergoing extracorporeal membrane oxygenation in ICU: An observational cohort study

First nosocomial infections in children supported by veno-arterial extracorporeal membrane oxygenation (VA-ECMO)